High rates of proven invasive fungal disease with the use of ibrutinib monotherapy for relapsed or refractory chronic lymphocytic leukemia.
Benjamin W TehWilliam ChuiSasanka HandunnettiConstantine TamLeon J WorthKarin A ThurskyMonica A SlavinPublished in: Leukemia & lymphoma (2019)